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The third stage of labor is associated with considerable maternal morbidity and mortality. The major complication is postpartum
hemorrhage (PPH), which is the leading cause of maternal morbidity and mortality worldwide. Whereas in the event of PPH due
to atony of the uterus there exist numerous treatment guidelines; for the management of retained placenta the general consensus
is more difficult to establish. Active management of the third stage of labour is generally accepted as standard of care as already
its duration is contributing to the risk of PPH. Despite scant evidence it is commonly advised that if the placenta has not been
expelled 30 minutes after delivery, manual removal of the placenta should be carried out under anaesthesia. Pathologic adhesion
of the placenta in the low risk situation usually is diagnosed at the time of delivery; therefore a pre- or intrapartum screening
opportunity for placenta accreta would be desirable. But diagnosis of abnormalities of placentation other than placenta previa
remains a challenge. Nevertheless the use of ultrasound and doppler sonography might be helpful in the third stage of labor. An
improvement might be the implementation of standardized operating procedures for retained placenta which could contribute to
a reduction of maternal morbidity.
1. Introduction
The third stage of labor is still associated with considerable
maternal morbidity and mortality. The major complication
is postpartum hemorrhage (PPH), which affects about 5%
of deliveries [1, 2]. Therefore it is the leading cause of
maternal morbidity and mortality worldwide [3]. In western
countries, such as the United Kingdom, it is the fifth most
common reason for maternal death after thromboembolism,
preeclampsia/eclampsia, genital tract sepsis, and amniotic
fluid embolism. It has a mortality rate of 0.39 : 100,000 [4].
Some ten years ago, an editorial titled “The retained
placenta—new insights into an old problem” was raising
hopes that this problem is to be solved soon [5]. Unfortu-
nately, it is still not.
Whereas in the event of PPH due to atony of the uterus
there exist numerous guidelines, recommendations, and
flowcharts for its management; in the treatment of retained
placenta the general consensus is more difficult to establish.
Retained placenta is an important cause of PPH and has an
incidence of 1 : 100 to 1 : 300 births [6, 7]. With this paper our
aim was to attract the obstetricians’ attention to the potential
risk of retained placenta in the low risk settingwhere it occurs
without prior warning and to present a possible flowchart for
the timing of treatment to reduce blood loss and therefore
maternal morbidity.
2. The Time Factor
In general it can be said that already the duration of the
third stage of labour is contributing to the risk of PPH as
the risk of major bleeding is believed to increase with time
elapsed after birth. Hence, active management of third stage
of labour using prophylactic oxytocics is accepted as standard
of care. Active management of the third stage of labour
involves administration of intravenous oxytocin, early cord
clamping, transabdominalmanualmassage of the uterus, and
controlled traction of the umbilical cord. Should this appear
insufficient, the next step is usually manual removal of the
placenta (MROP). However, the timing of this manoeuver
is difficult as the risk of PPH from leaving the placenta in
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situ has to be weighed against the knowledge that manual
removal can itself cause hemorrhage. It should also be borne
in mind that the placenta may be delivered spontaneously
up to 30 minutes or more after delivery of the child, without
major additional blood loss. The management questions that
thus need answering are When and how to detect increased
blood loss?When to call in support staff?When to contact the
anesthesiologist? Observation of routine practice shows that
MROP is regularly deferred beyond the limits recommended.
In the absence of immediate evidence of increased vaginal
bleeding, management is often conservative and expectant,
open to several different options, and paying little attention
to the time elapsed since birth.
In a study of over 12,000 births, Combs and Laros found
that the risk of hemorrhage increased after 30 minutes of
placental retention [8]. Similarly, Magann et al. found that
the risk of hemorrhage increased with time. In their study,
the risk of PPH was already significantly increased at 10
minutes and, using a receiving operator characteristic (ROC)
curve, they demonstrated that the optimal cut-off time for
the prediction of PPH was 18 minutes, with a sensitivity
of 31% and a specificity of 90% [9]. However, delaying the
manual removalwill lead to the spontaneous delivery ofmany
placentas.
Despite scant evidence it is commonly advised that if
the placenta has not been expelled 30 minutes after delivery
despite active management, MROP should be carried out
under anaesthesia. Clearly, in the published recommenda-
tions the choice of timing for manual removal depends on
the facilities available and the local risks associated with
both PPH and MROP. Thus the 2007 intrapartum guide-
lines produced for the UK government agency the National
Institute for Health and Clinical Excellence (NICE) suggest
30 minutes, [10] whereas the WHO manual for childbirth
suggests 60 minutes [11]. Accordingly, a survey in Europe
showed that time until manual removal of placenta in the
absence of bleeding varies widely between different countries,
from under 30 minutes (Spain and Hungary) to 60 minutes
and more (The Netherlands) [12].
3. Difficulties with Definition
There are different reasons for retained placenta and there
is a wide variety in the nomenclature for disturbances in
placental disruption. We believe the following classification
is sound: placenta adherens is caused by failed contraction
of the retroplacental myometrium, incarcerated placenta is
caused by a closed or closing cervix, and placenta accreta is
caused by abnormal placental implantation [13]. A part of the
placenta or the entire placenta is abnormally adherent to the
uterine wall without underlying decidua basalis. In placenta
increta the placental villi invade into the myometrium, while
percreta placenta is classified as placental villi penetrating
through the uterine serosa or the adjacent organs, usually the
bladder [14, 15]. As there is a fair probability for detecting
cases with percreta placenta before the onset of labour
due to ultrasound and/or magnetic resonance imaging and
therefore operative delivery can be plannedwith all necessary
precautions, it is almost impossible for the clinician to detect
or even distinguish between placenta accreta and increta
despite numerous attempts to do so with several imaging
techniques.
4. Risk Factors
Weeks observed a considerable variation in the retained pla-
centa rate between countries [7]. In less developed countries
it is less common (about 0.1% of all deliveries) but has a
high fatality rate. Inmore developed countries it affects about
3% of all vaginal deliveries but is very rarely associated with
maternal death. It is suggested that interventions common
in the most developed countries such as abortions, uterine
intervention, labour induction, and use of oxytocin could be
contributing to the increase in retained placenta rate with
increasing development.
Commonly named risk factors for disturbances in pla-
cental disruption, such as placenta accreta, are history of
retained placenta, previous caesarean section, maternal age
over 35 years, preterm labour, induced labour, multiparity,
previous uterine injury or surgery, uterine malformations,
infection, and preeclampsia [1, 3, 6–8, 14–18]. It is believed
that placenta accreta is becoming more common due to the
rising caesarean section rate and advancing maternal age,
both independent risk factors for placenta accreta [2, 17].
History of caesarean section and placenta previa are
often of special interest as risk factors for placenta accreta.
In a prospective observational cohort study of over 30,000
women who had caesarean delivery without labour, placenta
accreta was present in 0.24% of women undergoing their
first up to 6.74% of women undergoing their sixth or more
caesarean delivery. In women with placenta previa the risk
for placenta accreta was 3%, 11%, 40%, 61%, and 67% for
first, second, third, fourth, fifth, and sixth or more caesarean
deliveries. With every additional caesarean delivery the risk
for emergency hysterectomy was rising as well. Hysterectomy
was required in 0.65% for their first caesarean delivery and
increased up to 8.99% for their sixth or more caesarean
delivery [19].
In another study the incidence of placenta accreta in case
of placenta previa was 5%.With a previous caesarean section,
the incidence increased to 10% [1].
5. Avoiding Increased Blood Loss
Some studies showed promising results by injecting oxytocin
into the umbilical cord, as it increased the rate of spontaneous
expulsions of the placenta and fewer manual removals of
the placenta, but two Cochrane reviews, either investigating
umbilical cord injection of saline or oxytocin in the routine
management of the third stage of labour [20] or for the
reduction of MROP [21], were not able to detect a significant
reduction in the need forMROP.Nevertheless, umbilical vein
injection of oxytocin solution is an inexpensive and simple
intervention that could be performedwhile placental delivery
is awaited. However, high-quality randomized trials show
that the use of oxytocin has little or no effect.The same review
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showed a statistically lower incidence in manual removal of
placenta if prostaglandin solution was used. Unfortunately,
there were only two small trials contributing to this meta-
analysis [21].
Eller et al. published a study including 57 cases with
placenta accreta, where all women underwent hysterectomy.
In 15 cases an attempt was made to remove the placenta
manually, but these entire women required immediate hys-
terectomy for uncontrollable bleeding. The authors of this
study concluded that, in case of suspected placenta accreta,
scheduled caesarean hysterectomy without attempting pla-
cental removal is associated with a significantly reduced rate
of early morbidity compared with cases in which placental
removal is attempted [22].
6. Diagnosis
Diagnosis of placenta accreta is not based on universally
valid standard criteria but rather a diagnosis based on the
obstetricians’ impression and subjective judgement. Some
authors use only clinical criteria for the diagnosis of placenta
accreta, while others use histopathological criteria, which
is not always possible for obvious reasons. Some authors
distinguish between total and partial placenta accreta, a
diagnosis even more difficult to make. As well for the term
placenta adherens there is no consensus regarding exact
criteria for the definition. This may also be contributing to
the highly variable incidence of placenta accreta, with rates
reported in literature between 1 : 93,000 and 1 : 110 [16].
Aside from patients with placenta previa and patients
with a high risk of morbidly adherent placenta due to
obstetrical history, the diagnosis of placenta accreta is usually
made at the time of delivery. A prenatal screening for placenta
accreta, especially for woman with risk factors, would be
eligible. A prenatal diagnosis would allow a more planned
approach and minimize maternal blood loss. In literature
greyscale ultrasonography, colour Doppler imaging, and
magnetic resonance imaging (MRI) have been described as
alleged successful approaches to diagnose placenta accreta
antenatally [6, 15, 17, 18]. Esakoff and colleagues stated
that ultrasound examination is a good diagnostic test for
accreta in women with placenta previa and found this in
consistency with most other studies in the literature [23]. A
recent meta-analysis involving 3707 pregnancies showed a
sensitivity of 90.72% and a specificity of 96.94% of ultrasound
for the antenatal detection of invasive placentation [24].
There is a general consensus that sensitivity and specificity of
ultrasound are superior to those of MRI (sensitivity 80–85%,
specificity 65–100%) [25], but often both imaging techniques
are used in conjunction in women at risk. This is particularly
true when the placenta is posterior and in obese women.
However, prenatal diagnosis of placenta accreta in absence of
further abnormalities of placentation remains a challenge.
There are also few biochemical markers named which are
thought to have a diagnostic potential, such as elevated levels
of maternal serum creatinine kinase, alpha fetoprotein, and
𝛽-human chorionic gonadotropin [18]. Others promisingly
described cell-free fetal DNA, placental mRNA, and DNA
microarray as potential tools for the diagnosis of abnormali-
ties of placental invasion [15, 26, 27].
But so far there exists no diagnostic tool ready to use in
daily routine for prenatal diagnosis of placenta accreta. The
sensitivity of theoretically possible test methods also depends
on the degree and extent of the abnormal placental invasion.
In our experience prenatal diagnosis is almost impossible in
the low risk population, where often the parturient is seen
in the maternity hospital only for childbirth. We only can
assume that these patientsmost probably have not undergone
prenatal ultrasound examination with the very question of
morbidly adherent placenta.
Nevertheless, the use of colour Doppler sonography in
the third stage of labour has been promisingly introduced by
Krapp et al. [6, 28]. They examined the third stage of labour
using greyscale and colour Doppler ultrasound. In cases
with normal placental separation they found cessation of
blood flow between placenta and myometrium immediately
after birth. Suggestive of placenta accreta was persistent
blood flow from the myometrium deep into the placenta
demonstrated by colour Doppler ultrasound. According to
the authors thismethod allows a quicker diagnosis of placenta
accreta and maternal blood loss can be minimized by early
manual removal. As an ultrasound machine should be easily
available in a well-equipped delivery unit it is advisable
to use ultrasound in the third stage of labour complicated
by retention of the placenta. With a gain of experience
in judging the separation of the placenta from the uterine
muscle ultrasound imaging may develop into a useful tool in
the management of pathologic third stage of labour.
7. Treatment
Audureau et al. were able to show that the implementation
of a multifaceted intervention scheme for the prevention and
management of postpartumhemorrhage can be successful. In
such way the median delay for second-line pharmacological
treatment was significantly shortened from 80min before
introduction to 32.5min afterwards [29]. Comparable to a
strict work flow as already developed and implemented in
most large delivery units for emergency caesarean section
(target of decision delivery time < 20min) a similar stan-
dardized protocol for manual removal of placenta might be
useful. In Figure 1 we present a showcase flowchart for cases
with retained placenta with special emphasis on the time
frame. We believe that already strict observation of time, use
of ultrasound for evaluation of the grade of placental detach-
ment, and early involvement of support staff (i.e., second
midwife, anaesthesiologist) might contribute to a reduction
of maternal morbidity. Needless to say, the suggested time
frame is only applicable in the absence of increased vaginal
bleeding, and its efficacy has to be proven in a controlled
trial. In case of an increased blood loss during third stage of
labour ideally standardized operating procedures are already
implemented.
In conclusion, retained placenta remains a problem of the
third stage of labour, which in the low risk setting usually is
occurring without prior warning. In daily routine adherence
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Figure 1: Flowchart for the treatment of retained placenta with special emphasis on the time frame.
to a strict protocol of active management of third stage of
labour may be helpful to minimize time interval between
birth and delivery of placenta and therefore minimize post-
partum complications. Further work is needed to proof this
concept.
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